Database | Time span | Search strategy | No of hits |
The Cochrane Hepato‐Biliary Group Controlled Trials Register | November 2016. | (terlipressin* OR glypressin* OR vasoconstric*) AND hepatorenal syndrom* | 31 |
The Cochrane Central Register of Controlled Trials (CENTRAL) | 2016, Issue 11. | #1 MeSH descriptor: [Vasoconstrictor Agents] explode all trees #2 terlipressin* or glypressin* or vasoconstric* #3 #1 or #2 #4 MeSH descriptor: [Hepatorenal Syndrome] explode all trees #5 hepatorenal syndrom* #6 #4 or #5 #7 #3 and #6 |
35 |
MEDLINE Ovid | 1946 to November 2016. | 1. exp Vasoconstrictor Agents/ 2. (terlipressin* or glypressin* or vasoconstric*).mp. [mp=title, original title, abstract, name of substance word, subject heading word] 3. 1 or 2 4. exp Hepatorenal Syndrome/ 5. hepatorenal syndrom*.mp. [mp=title, original title, abstract, name of substance word, subject heading word] 6. 4 or 5 7. 6 and 3 8. (random* or blind* or placebo* or meta‐analysis).mp. [mp=title, original title, abstract, name of substance word, subject heading word] 9. 8 and 7 |
59 |
Embase Ovid | 1974 to November 2016. | 1. exp Terlipressin/ 2. exp Vasoconstrictor Agent/ 3. (terlipressin* or glypressin* or vasoconstric*).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] 4. 1 or 3 or 2 5. exp Hepatorenal Syndrome/ 6. hepatorenal syndrom*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] 7. 6 or 5 8. 4 and 7 9. (random* or blind* or placebo* or meta‐analysis).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name] 10. 8 and 9 |
204 |
Science Citation Index Expanded (Web of Science) | 1900 to November 2016. | #5 #4 AND #3 #4 TS=(random* or blind* or placebo* or meta‐analysis) #3 #1 AND #2 #2 TS=(hepatorenal syndrom*) #1 TS=(terlipressin* or glypressin* or vasoconstric*) |
118 |